Li Auto jumps following Q3 results and Q4 guidance Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Krystal Biotech (KRYS) up 162% after announcing the primary endpoint of the GEM-3 trial of investigational beremagene geperpavec met statistical significance
- Newegg Commerce (NEGG) up 4% after expanding into two new distribution centers and reaffirming its FY21 sales outlook
- Allbirds (BIRD) up 2% after several firms initiated coverage of the stock
UP AFTER EARNINGS -
- Li Auto (LI) up 8%
- Quhuo (QH) up 1%
LOWER -
- Sigilon Therapeutics (SGTX) down 5% after reporting that fibrosed spheres were observed during a retrieval procedure in a patient in its Phase 1/2 study of SIG-001 in severe or moderately severe hemophilia A
- Fennec (FENC) down 47% after announcing that it expects to receive a Complete Response Letter after the PDUFA target action date of November 27 from the FDA regarding its New Drug Application for Pedmark
- Merck (MRK) down 3% after Citi analyst Andrew Baum downgraded shares to Neutral from Buy with a price target of $85, down from $105
Symbols:
KRYS NEGG BIRD LI QH SGTX FENC MRK Keywords: Fly Intel, Wall Street, Top Stories, Stocks